SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 114 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is 1.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $12,697,000 | -44.8% | 141,000 | -40.0% | 0.27% | -63.6% |
| Q1 2020 | $22,988,000 | -15.2% | 235,000 | +11.9% | 0.73% | -15.6% |
| Q4 2019 | $27,098,000 | -5.8% | 210,000 | -45.0% | 0.86% | -26.3% |
| Q3 2019 | $28,772,000 | -38.7% | 382,000 | +23.6% | 1.17% | -30.5% |
| Q2 2019 | $46,956,000 | +2.1% | 309,025 | -19.9% | 1.69% | -4.4% |
| Q1 2019 | $46,007,000 | +23.3% | 386,000 | +12.9% | 1.76% | +18.2% |
| Q4 2018 | $37,301,000 | -22.0% | 341,800 | +15.5% | 1.49% | -12.8% |
| Q3 2018 | $47,807,000 | +22.2% | 296,000 | 0.0% | 1.71% | +24.6% |
| Q2 2018 | $39,125,000 | +728.4% | 296,000 | +196.0% | 1.37% | +524.5% |
| Q3 2013 | $4,723,000 | – | 100,000 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |